JavaScript NENÍ povolen !

Prosím povolte JavaScript.

* Zobrazit nápovědu

Pracoviště: Department of Oncology Karmanos Cancer Institut...

1 záznamů v Medvik Filtry

Článek

A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab

Mikhael, Joseph
Autor Mikhael, Joseph Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ, USA
Belhadj-Merzoug, Karim
Autor Belhadj-Merzoug, Karim Unité Hémopathies Lymphoïdes, CHU Henri Mondor, Créteil, France
Hulin, Cyrille
Autor Hulin, Cyrille Service d'hématologie, CHRU Hôpitaux de Brabois, Nancy, France
Vincent, Laure
Autor Vincent, Laure ORCID Département d'hématologie Clinique, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
Moreau, Philippe
Autor Moreau, Philippe Hematology Department, Nantes University Hospital, Nantes, France
Gasparetto, Cristina
Autor Gasparetto, Cristina Duke Cancer Institute, Duke University, Durham, NC, USA
Pour, Ludek
Autor Pour, Ludek Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
Spicka, Ivan
Autor Spicka, Ivan 1st Department of Medicine-Department of Hematology First Faculty of Medicine Charles University and General Hospital in Prague, Prague, Czech Republic
Vij, Ravi
Autor Vij, Ravi Division of Medical Oncology, Washington University, St Louis, MO, USA
Zonder, Jeffrey
Autor Zonder, Jeffrey Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA

Blood cancer journal. 2021 ; 11 (5) : 89. [pub] 20210512

Blood Cancer J
ISSN 2044-5385
Medvik
Zdroj